TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,064
|
0 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
1,621
|
-24 | |
| EBITDA |
1,608
|
-24 | |
| Total assets |
3,253
|
1,655 | |
| Current assets |
1,126
|
25 | |
| Current liabilities |
122
|
10 | |
| Equity capital |
3,010
|
1,615 | |
| - share capital |
51
|
47 | |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
92.5%
|
97.6% | |
| Turnover per employee | 2,064 | ||
| Profit as a percentage of turnover | 78.5% | ||
| Return on assets (ROA) |
49.8%
|
-1.5% | |
| Current ratio |
923.0%
|
250.0% | |
| Return on equity (ROE) |
53.9%
|
-1.5% | |
| Change turnover |
2,064
|
0 | |
| Change turnover % | -61% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.